
  
    
      
        Background_NNP
        Vitamin_NNP E_NNP is_VBZ an_DT essential_JJ nutrient_NN ,_, the_DT main_JJ lipid_NN
        soluble_JJ antioxidant_NN ,_, and_CC plays_VBZ a_DT significant_JJ role_NN in_IN
        protecting_VBG biological_JJ membranes_NNS and_CC lipoproteins_NNS from_IN
        damage_NN caused_VBN by_IN free_JJ radicals_NNS generated_VBN during_IN lipid_NN
        peroxidation_NN [_NN 1_CD 2_CD 3_CD ]_NN ._. Recent_JJ information_NN suggests_VBZ that_DT
        vitamin_NN E_NNP also_RB has_VBZ functions_NNS unrelated_JJ to_TO its_PRP$ role_NN as_IN an_DT
        antioxidant_NN [_NN 4_CD ]_NN ._. Vitamin_NNP E_NNP is_VBZ often_RB equated_VBN only_RB with_IN
        alpha-tocopherol_JJ since_IN this_DT form_NN is_VBZ the_DT most_RBS potent_JJ in_IN
        protecting_VBG the_DT fetuses_NNS of_IN pregnant_JJ female_JJ rats_NNS from_IN death_NN
        and_CC resorption_NN ._. Vitamin_NNP E_NNP is_VBZ ,_, however_RB ,_, not_RB a_DT single_JJ
        compound_NN and_CC refers_VBZ to_TO at_IN least_JJS four_CD tocopherols_NNS (_( alpha-_NN ,_,
        beta-_NN ,_, delta-_NN and_CC gamma-tocopherol_JJ )_) and_CC four_CD tocotrienols_NNS
        (_( alpha-_NN ,_, beta-_NN ,_, delta-_NN and_CC gamma-tocotrienol_JJ )_) ._.
        Alpha-tocopherol_NNP and_CC gamma-tocopherol_JJ (_( see_VB Figure_NN 1_LS )_) are_VBP
        the_DT two_CD major_JJ forms_NNS of_IN vitamin_NN E_NNP found_VBD in_IN human_JJ plasma_NN and_CC
        tissues_NNS ._. Under_IN 
        in_IN vitro_NN conditions_NNS ,_, alpha-_NN and_CC
        gamma-tocopherol_JJ have_VBP very_RB similar_JJ abilities_NNS to_TO inhibit_VB
        lipid_NN peroxidation_NN in_IN large_JJ unilamellar_NN liposomes_NNS [_NN 5_CD ]_NN ._.
        The_DT dietary_JJ intake_NN of_IN gamma-tocopherol_JJ is_VBZ at_IN least_JJS two_CD
        times_NNS that_IN of_IN alpha-tocopherol_JJ in_IN Western_JJ diets_NNS ._. The_DT levels_NNS
        of_IN alpha-tocopherol_JJ in_IN human_JJ plasma_NN are_VBP ,_, nevertheless_RB ,_,
        about_IN four_CD times_NNS higher_JJR than_IN those_DT of_IN gamma-tocopherol_JJ ._.
        Both_DT alpha-_NN and_CC gamma-tocopherol_JJ are_VBP absorbed_VBN from_IN the_DT
        intestine_NN and_CC secreted_JJ into_IN chylomicrons_NNS equally_RB well_RB [_NN 6_CD 7_CD
        ]_NN ._. The_DT selective_JJ retention_NN of_IN alpha-tocopherol_JJ in_IN plasma_NN
        is_VBZ attributed_VBN to_TO a_DT number_NN of_IN factors_NNS such_JJ as_IN the_DT hepatic_JJ
        alpha-tocopherol_JJ transfer_NN protein_NN (_( alpha-_NN TTP_NNP )_) ,_, which_WDT
        preferentially_RB incorporates_VBZ alpha-tocopherol_JJ (_( over_IN
        gamma-tocopherol_JJ )_) into_IN very_RB low_JJ density_NN lipoprotein_NN [_NN 8_CD 9_CD
        10_CD ]_NN ._. Indeed_RB ,_, the_DT affinity_NN of_IN the_DT different_JJ forms_NNS of_IN
        vitamin_NN E_NNP for_IN the_DT alpha-_NN TTP_NNP protein_NN appears_VBZ to_TO be_VB a_DT primary_JJ
        determinant_NN of_IN their_PRP$ plasma_NN levels_NNS [_NN 8_CD ]_NN ._. In_IN addition_NN ,_,
        there_EX is_VBZ evidence_NN suggesting_VBG that_IN gamma-tocopherol_JJ is_VBZ
        preferentially_RB catabolized_JJ to_TO a_DT water-soluble_JJ form_NN (_( 2_CD ,_, 7_CD ,_,
        8_CD -_: trimethyl-_NN 2_CD -_: (_( beta-carboxyethyl_JJ )_) -_: 6_CD -_: hydroxychroman_NN or_CC
        gamma-_NN CEHC_NNP )_) by_IN side_NN chain_NN oxidation_NN [_NN 11_CD 12_CD ]_NN ._.
        It_PRP is_VBZ also_RB possible_JJ that_IN a_DT more_RBR rapid_JJ cellular_JJ uptake_NN of_IN
        gamma-tocopherol_JJ (_( and_CC removal_NN from_IN plasma_NN )_) could_MD contribute_VB
        to_TO the_DT preferential_JJ maintenance_NN of_IN alpha-tocopherol_JJ in_IN
        plasma_NN ._. A_DT more_RBR rapid_JJ cellular_JJ accumulation_NN of_IN
        gamma-tocopherol_JJ (_( compared_VBN to_TO alpha-tocopherol_JJ )_) would_MD also_RB
        have_VB major_JJ physiological_JJ consequences_NNS ._. The_DT protection_NN of_IN
        subcellular_NN organelles_NNS and_CC cellular_JJ DNA_NNP from_IN free_JJ radical_JJ
        damage_NN is_VBZ likely_JJ to_TO be_VB primarily_RB dependent_JJ upon_IN
        intracellular_NN vitamin_NN E_NNP levels_NNS as_IN opposed_VBN to_TO plasma_NN vitamin_NN
        E_NNP levels_NNS ._. Surprisingly_RB ,_, there_EX have_VBP been_VBN very_RB few_JJ studies_NNS
        comparing_VBG the_DT cellular_JJ uptakes_NNS of_IN alpha-_NN and_CC
        gamma-tocopherol_JJ ._. Tran_NNP and_CC Chan_NNP [_NN 13_CD ]_NN found_VBD a_DT
        preferentially_RB uptake_NN (_( three_CD fold_VB higher_JJR after_IN four_CD hours_NNS
        of_IN incubation_NN )_) of_IN gamma-tocopherol_JJ compared_VBN to_TO
        alpha-tocopherol_JJ in_IN cultured_JJ human_JJ umbilical_JJ endothelial_NN
        cells_NNS ._. In_IN contrast_NN ,_, Jiang_NNP 
        et_CC al_NN ._. [_NN 14_CD ]_NN found_VBD a_DT similar_JJ
        incorporation_NN of_IN both_DT alpha-_NN and_CC gamma-tocopherol_JJ into_IN
        RAW_NNP 264_CD ._. 7_CD macrophages_NNS and_CC only_RB a_DT slightly_RB higher_JJR (_( 30_CD %_NN )_)
        incorporation_NN of_IN gamma-tocopherol_JJ (_( compared_VBN to_TO
        alpha-tocopherol_JJ )_) in_IN A_DT 549_CD endothelial_NN cells_NNS ._.
        In_IN this_DT investigation_NN ,_, we_PRP studied_VBD the_DT uptake_NN and_CC
        depletion_NN of_IN alpha-tocopherol_JJ and_CC gamma-tocopherol_JJ as_IN well_RB
        as_IN their_PRP$ quinone_NN oxidation_NN products_NNS (_( see_VB Figure_NN 2_LS )_) by_IN
        RAW_NNP 264_CD ._. 7_CD murine_NN macrophages_NNS ._. There_EX are_VBP no_DT previous_JJ studies_NNS
        on_IN the_DT cellular_JJ uptake_NN tocopheryl_NN quinones_NNS ._. We_PRP found_VBD that_IN
        gamma-tocopherol_JJ was_VBD taken_VBN up_RP more_RBR rapidly_RB and_CC accumulated_VBN
        to_TO higher_JJR levels_NNS than_IN alpha-tocopherol_JJ in_IN RAW_NNP 264_CD ._. 7_CD
        macrophages_NNS ._. In_IN addition_NN ,_, we_PRP found_VBD that_DT presence_NN of_IN
        gamma-tocopherol_JJ dramatically_RB increased_VBD the_DT cellular_JJ uptake_NN
        of_IN alpha-tocopherol_JJ ._. We_PRP also_RB describe_VBP a_DT novel_NN high_JJ pressure_NN
        liquid_JJ chromatography_NN (_( HPLC_NNP )_) method_NN for_IN simultaneously_RB
        separating_VBG and_CC quantifying_VBG levels_NNS of_IN alpha-tocopherol_JJ ,_,
        alpha-tocopheryl_JJ quinone_NN ,_, gamma-tocopherol_JJ and_CC
        gamma-tocopheryl_JJ quinone_NN ._.
      
      
        Methods_NNP
        
          Reagents_NNP and_CC materials_NNS
          RPMI-_NNP 1640_CD medium_NN without_IN phenol_NN red_JJ ,_, cell_NN culture_NN
          freezing_NN medium_NN containing_VBG DMSO_NNP ,_, fetal_JJ bovine_JJ serum_NN
          (_( FBS_NNP )_) ,_, penicillin_NN ,_, streptomycin_NN ,_, 7_CD ._. 5_CD %_NN bovine_JJ serum_NN
          albumin_NN (_( BSA_NNP )_) ,_, phosphate_NN buffer_NN saline_NN (_( PBS_NNP ,_, pH_NN =_SYM 7_CD ._. 4_LS )_) ,_,
          and_CC trypan_NN blue_NN were_VBD purchased_VBN from_IN Life_NNP Technologies_NNPS
          (_( Grand_NNP Island_NNP ,_, NY_NNP )_) ._. Rac-_NNP 5_CD ,_, 7_CD -_: dimethyl_NN tocol_NN was_VBD purchased_VBN
          from_IN Matreya_NNP (_( Pleasant_NNP Gap_NNP ,_, PA_NNP )_) ._. Alpha-tocopherol_NNP was_VBD
          obtained_VBN from_IN Eastman_NNP (_( Kingsport_NNP ,_, TN_NNP )_) and_CC
          gamma-tocopherol_JJ was_VBD obtained_VBN Tama_NNP Biochemical_NNP Co_NNP ._.
          (_( Tokyo_NNP ,_, Japan_NNP )_) ._. Alpha-tocopheryl_NNP quinone_NN and_CC
          gamma-tocopheryl_JJ quinone_NN were_VBD synthesized_JJ as_IN described_VBN
          below_IN ._.
        
        
          Cell_NNP culture_NN
          RAW_NNP 264_CD ._. 7_CD murine_NN macrophages_NNS (_( American_NNP Type_NNP Culture_NNP
          Collection_NNP ,_, Rockville_NNP ,_, MD_NNP )_) were_VBD cultured_JJ at_IN 37_CD °_NN C_NNP in_IN a_DT
          humidified_JJ incubator_NN (_( 95_CD %_NN air_NN with_IN 5_CD %_NN CO_NNP 
          2_LS )_) in_IN RPMI-_NNP 1640_CD medium_NN with_IN 10_CD %_NN
          fetal_JJ bovine_JJ serum_NN (_( FBS_NNP )_) ,_, 50_CD units_NNS /_NN ml_NN penicillin_NN ,_, and_CC 50_CD
          mg_NN /_NN ml_NN streptomycin_NN (_( culture_NN medium_NN )_) ._.
        
        
          Enrichment_NNP of_IN tocopherol_NN (_( or_CC tocopheryl_NN quinone_NN )_) in_IN
          culture_NN medium_NN
          A_DT 50_CD μl_NN aliquot_NN of_IN tocopherol_NN (_( or_CC tocopheryl_NN quinone_NN )_)
          solution_NN in_IN ethanol_NN was_VBD placed_VBN in_IN glass_NN tube_NN and_CC dried_VBD
          under_IN N_NNP 
          2_CD ._. After_IN the_DT addition_NN of_IN 1_CD ._. 0_CD ml_NN of_IN
          7_CD ._. 5_CD %_NN BSA_NNP the_DT mixture_NN was_VBD vortexed_JJ for_IN 2_CD min_NN ,_, 74_CD ._. 0_CD ml_NN
          culture_NN medium_NN added_VBD ,_, and_CC the_DT mixture_NN vortexed_JJ again_RB for_IN
          2_CD min_NN ._. The_DT final_JJ concentration_NN of_IN tocopherol_NN (_( or_CC
          tocopheryl_NN quinone_NN )_) in_IN the_DT culture_NN medium_NN was_VBD determined_VBN
          by_IN HPLC_NNP (_( see_VB below_IN )_) ._.
        
        
          Uptake_NNP and_CC depletion_NN of_IN tocopherols_NNS (_( or_CC tocopheryl_NN
          quinones_NNS )_) in_IN cells_NNS
          To_TO define_VB the_DT time_NN course_NN of_IN tocopherol_NN (_( or_CC tocopheryl_NN
          quinone_NN )_) accumulation_NN ,_, adherent_NN cells_NNS (_( 2_CD ×_NN 10_CD 6_CD /_NN well_RB )_)
          were_VBD subcultured_JJ in_IN 12_CD well_RB falcon_NN tissue_NN culture_NN plates_NNS
          with_IN medium_NN enriched_JJ with_IN about_IN 5_CD μM_NN tocopherol_NN (_( or_CC about_IN
          0_CD ._. 5_CD μM_NN quinone_NN )_) (_( 3_CD ml_NN /_NN well_RB )_) ._. After_IN 6_CD hr_NN (_( the_DT uptake_NN
          phase_NN )_) ,_, the_DT medium_NN was_VBD replaced_VBN with_IN fresh_JJ medium_NN without_IN
          tocopherol_NN (_( or_CC quinone_NN )_) and_CC the_DT depletion_NN of_IN tocopherols_NNS
          (_( or_CC quinones_NNS )_) followed_VBN for_IN an_DT additional_JJ 4_CD hours_NNS (_( the_DT
          depletion_NN phase_NN )_) ._. During_IN the_DT course_NN of_IN the_DT cell_NN culture_NN
          experiment_NN ,_, a_DT 400_CD μl_NN aliquot_NN of_IN medium_NN was_VBD removed_VBN every_DT
          2_CD hr_NN and_CC placed_VBN in_IN a_DT glass_NN vial_NN for_IN tocopherol_NN (_( or_CC
          quinone_NN )_) measurement_NN and_CC the_DT remaining_VBG medium_NN removed_VBN ._.
          The_DT adherent_NN cells_NNS in_IN the_DT well_NN were_VBD washed_VBN three_CD times_NNS
          with_IN 1_CD ._. 0_CD ml_NN of_IN PBS_NNP ,_, and_CC the_DT cells_NNS overlaid_VBN with_IN 400_CD μl_NN of_IN
          lysis_NNS buffer_NN (_( 1_CD %_NN Triton_NNP X-_NNP 100_CD in_IN pH_NN 7_CD ._. 5_CD ,_, 20_CD mM_NN HEPES_NNP
          buffer_NN with_IN 0_CD ._. 1_CD mM_NN EDTA_NNP )_) ,_, scraped_JJ ,_, and_CC collected_VBD into_IN a_DT
          glass_NN vial_NN for_IN tocopherol_NN analysis_NN by_IN HPLC_NNP ,_, and_CC for_IN
          protein_NN determination_NN by_IN the_DT BCA_NNP protein_NN assay_NN (_( Pierce_NNP ,_,
          Rockford_NNP ,_, IL_NNP )_) ._. For_IN each_DT experiment_NN ,_, three_CD wells_NNS were_VBD used_VBN
          per_IN time_NN point_NN and_CC each_DT experiment_NN was_VBD performed_VBN in_IN
          duplicate_VB ._. Statistical_NNP comparisons_NNS were_VBD made_VBN by_IN use_NN of_IN
          the_DT Student_NNP 's_POS 
          t_NN -_: test_NN ._.
        
        
          Tocopherol_NNP (_( or_CC tocopheryl_NN quinone_NN )_) measurement_NN by_IN
          HPLC_NNP with_IN electrochemical_JJ detection_NN
          The_DT medium_NN sample_NN (_( or_CC cell_NN sample_NN )_) was_VBD mixed_VBN with_IN 1_CD ._. 0_CD
          ml_NN ethanol_NN and_CC 1_CD ._. 0_CD ml_NN hexane_NN containing_VBG 10_CD μg_NN /_NN ml_NN
          2_CD ,_, 6_CD -_: di-tert-butyl-_JJ 4_CD -_: methylphenol_NN (_( BHT_NNP )_) ,_, and_CC
          rac-_NN 5_CD ,_, 7_CD -_: dimethyl_NN tocol_NN as_IN an_DT internal_JJ standard_NN ._. The_DT
          rac-_NN 5_CD ,_, 7_CD -_: dimethyl_NN tocol_NN internal_JJ standard_NN was_VBD found_VBN to_TO be_VB
          very_RB useful_JJ since_IN it_PRP did_VBD not_RB elute_NN in_IN the_DT same_JJ position_NN
          as_IN gamma-tocopheryl_JJ quinone_NN as_IN does_VBZ tocol_NN
          (_( 2_CD -_: methyl-_NN 2_CD -_: (_( 4_CD ,_, 8_CD ,_, 12_CD -_: trimethyltridecyl_NN )_) chroman-_NN 6_CD -_: ol_NN )_) which_WDT
          is_VBZ typically_RB used_VBN as_IN an_DT internal_JJ standard_NN ._. After_IN
          vortexing_VBG ,_, the_DT mixture_NN was_VBD centrifuged_JJ at_IN 1020_CD ×_NN g_SYM for_IN 5_CD
          min_NN ,_, and_CC a_DT 400_CD μl_NN aliquot_NN of_IN the_DT upper_JJ layer_NN removed_VBD ,_,
          dried_VBD under_IN N_NNP 
          2_CD ,_, and_CC taken_VBN up_RP in_IN 100_CD μl_NN of_IN mobile_JJ
          phase_NN ._. The_DT mobile_JJ phase_NN was_VBD methanol_NN :_: water_NN (_( 90_CD :_: 10_CD )_)
          containing_VBG 3_CD FM_NNP EDTA_NNP and_CC 20_CD mM_NN ammonium_NN acetate_NN ,_, pH_NN 4_CD ._. 4_CD ._.
          The_DT tocopherol_NN (_( or_CC tocopheryl_NN quinone_NN )_) was_VBD measured_VBN using_VBG
          a_DT HPLC_NNP equipped_VBD with_IN a_DT Coulochem_NNP II_NNP Electrochemical_NNP
          Detector_NNP ,_, a_DT ESA_NNP Model_NNP 580_CD Solvent_NNP Delivery_NN Module_NNP ,_, a_DT
          Column_NNP Catecholamine_NNP HR-_NNP 80_CD (_( C_NNP 18_CD ,_, 3_CD mm_NN ,_, 8_CD cm_NN )_) ,_, a_DT Model_NNP
          5011_CD Analytical_NNP Cell_NNP ,_, a_DT Model_NNP 5020_CD Guard_NNP Cell_NNP
          (_( Chelmsford_NNP ,_, MA_NNP )_) ,_, a_DT PE_NNP Nelson_NNP 900_CD Series_NNP Interface_NNP with_IN
          PE_NNP Nelson_NNP Turbochrom_NNP V_NNP 4_CD software_NN (_( Perkin_NNP Elmer_NNP ,_, San_NNP Jose_NNP ,_,
          CA_NNP )_) ._. The_DT flow_NN rate_NN was_VBD adjusted_VBN to_TO 1_CD ._. 5_CD ml_NN /_NN min_NN with_IN E_NNP 1_CD =_SYM
          -_: 600_CD mV_NN (_( the_DT first_NN analytical_JJ cell_NN potential_JJ )_) ,_, E_NNP 2_CD =_SYM 400_CD
          mV_NN (_( the_DT second_NN analytical_JJ cell_NN potential_JJ and_CC E_NNP 3_CD =_SYM 300_CD mV_NN
          (_( the_DT conditioning_NN cell_NN potential_JJ )_) ._. The_DT response_NN factors_NNS
          of_IN tocopherols_NNS (_( or_CC tocopheryl_NN quinones_NNS )_) relative_JJ to_TO tocol_NN
          were_VBD determined_VBN in_IN triplicate_NN ._. The_DT concentrations_NNS of_IN
          alpha-tocopherol_JJ ,_, gamma-tocopherol_JJ ,_, rac-_NN 5_CD ,_, 7_CD -_: tocol_NN ,_,
          alpha-tocopheryl_JJ quinone_NN ,_, and_CC gamma-tocopheryl_JJ quinone_NN in_IN
          the_DT standard_JJ solutions_NNS were_VBD measured_VBN using_VBG a_DT Spectronic_NNP
          3000_CD Array_NNP Spectrometer_NNP (_( Milton_NNP Roy_NNP ,_, Rochester_NNP ,_, NY_NNP )_) and_CC
          published_VBN extinction_NN coefficients_NNS [_NN 15_CD ]_NN ._.
        
        
          Synthesis_NNP and_CC purification_NN of_IN alpha-tocopheryl_JJ
          quinone_NN (_( or_CC gamma-tocopheryl_JJ quinone_NN )_)
          FeCl_NNP 
          3_CD ·_NN 6_CD H_NNP 
          2_CD O_NNP (_( 1360_CD mg_NN )_) was_VBD dissolved_VBN in_IN 30_CD ml_NN
          ethanol_NN ,_, and_CC 530_CD mg_NN of_IN alpha-tocopherol_JJ (_( or_CC
          gamma-tocopherol_JJ )_) was_VBD dissolved_VBN in_IN 40_CD ml_NN ethanol_NN ._. Both_DT
          solutions_NNS were_VBD mixed_JJ and_CC placed_VBN in_IN water_NN bath_NN at_IN 50_CD °_NN C_NNP ._.
          After_IN 3_CD hr_NN ,_, a_DT 35_CD ml_NN aliquot_NN of_IN the_DT reaction_NN mixture_NN was_VBD
          placed_VBN in_IN a_DT separatory_NN funnel_VB ,_, mixed_VBN with_IN 50_CD ml_NN of_IN ether_NN ,_,
          washed_VBN with_IN 50_CD ml_NN of_IN water_NN ,_, then_RB washed_VBN with_IN 50_CD ml_NN of_IN
          0_CD ._. 15_CD M_NNP EDTA_NNP to_TO chelate_NN Fe_NNP ions_NNS ._. After_IN the_DT ether_NN layer_NN was_VBD
          dried_VBN by_IN evaporation_NN in_IN a_DT rotary_JJ evaporator_NN ,_, the_DT crude_NN
          quinone_NN oil_NN was_VBD dissolved_VBN in_IN 10_CD ml_NN ethanol_NN and_CC stored_VBD in_IN
          a_DT freezer_NN at_IN -_: 20_CD °_NN C_NNP ._. The_DT crude_NN sample_NN of_IN tocopheryl_NN
          quinone_NN was_VBD purified_JJ using_VBG a_DT HPLC_NNP system_NN equipped_VBN with_IN a_DT
          Dynamax_NNP PC_NNP UV-M_NNP Multiple_NNP Wavelength_NNP Detector_NNP (_( Rainin_NNP ,_,
          Woburn_NNP ,_, MA_NNP )_) ,_, a_DT model_NN 2350_CD HPLC_NNP Pump_NNP ,_, a_DT C_NNP 18_CD Column_NNP (_( 5_CD mm_NN ,_,
          250_CD mm_NN )_) (_( ISCO_NNP ,_, Lincoln_NNP ,_, NE_NNP )_) ._.
        
      
      
        Results_NNS
        
          The_DT uptake_NN and_CC depletion_NN of_IN tocopherols_NNS (_( separately_RB
          and_CC together_RB )_)
          Confluent_NNP RAW_NNP 264_CD ._. 7_CD macrophages_NNS were_VBD incubated_JJ with_IN
          either_DT 5_CD ._. 6_CD μM_NN alpha-tocopherol_JJ or_CC 4_CD ._. 9_CD μM_NN gamma-tocopherol_JJ
          (_( Figure_NN 3_CD A_DT )_) or_CC with_IN both_DT tocopherols_NNS together_RB (_( Figure_NN
          3_CD Bwith_NNP alpha-tocopherol_JJ at_IN 4_CD ._. 6_CD μM_NN and_CC gamma-tocopherol_JJ at_IN
          5_CD ._. 2_CD μM_NN )_) and_CC the_DT uptake_NN of_IN tocopherols_NNS measured_VBN during_IN 6_CD
          hours_NNS of_IN incubation_NN ._. Uptake_NNP is_VBZ defined_VBN as_IN the_DT net_JJ
          difference_NN between_IN tocopherol_NN transported_VBN into_IN the_DT cells_NNS
          and_CC loss_NN due_JJ to_TO catabolism_NN and_CC /_NN or_CC 
          in_IN vitro_NN oxidation_NN ._. After_IN 6_CD hours_NNS ,_,
          the_DT medium_NN with_IN tocopherols_NNS was_VBD removed_VBN and_CC replaced_VBN with_IN
          medium_NN not_RB containing_VBG tocopherols_NNS and_CC depletion_NN of_IN
          tocopherols_NNS followed_VBN for_IN 4_CD hours_NNS ._.
          After_IN 6_CD hours_NNS of_IN incubating_VBG macrophages_NNS with_IN either_DT
          alpha-_NN or_CC gamma-tocopherol_JJ (_( Figure_NN 3_CD A_DT )_) ,_, the_DT intracellular_NN
          levels_NNS of_IN gamma-tocopherol_JJ were_VBD at_IN least_JJS six_CD fold_VB higher_JJR
          than_IN the_DT levels_NNS of_IN alpha-tocopherol_JJ (_( p_NN <_NN 0_CD ._. 001_CD )_) ._. A_DT
          major_JJ goal_NN of_IN this_DT research_NN was_VBD to_TO determine_VB if_IN
          alpha-tocopherol_JJ and_CC gamma-tocopherol_JJ interacted_JJ with_IN
          each_DT other_JJ so_RB as_IN influence_NN their_PRP$ uptake_NN and_CC depletion_NN ._.
          Figure_NN 3_CD Bshows_NNP the_DT uptake_NN and_CC depletion_NN of_IN
          alpha-tocopherol_JJ and_CC gamma-tocopherol_JJ when_WRB both_DT were_VBD
          incubated_JJ together_RB with_IN macrophages_NNS ._. It_PRP is_VBZ clear_JJ (_( compare_VB
          Figure_NN 3_CD Ato_NNP 3_CD B_NNP )_) that_IN the_DT presence_NN of_IN gamma-tocopherol_JJ
          considerably_RB enhanced_VBD the_DT uptake_NN of_IN alpha-tocopherol_JJ (_( p_NN
          <_NN 0_CD ._. 001_CD )_) ._. The_DT presence_NN of_IN alpha-tocopherol_JJ did_VBD not_RB ,_,
          however_RB ,_, markedly_RB enhance_VB the_DT uptake_NN of_IN gamma-tocopherol_JJ ._.
          After_IN washing_VBG with_IN fresh_JJ medium_NN without_IN tocopherols_NNS ,_, the_DT
          macrophage_NN levels_NNS of_IN both_DT alpha-tocopherol_JJ and_CC
          gamma-tocopherol_JJ decreased_VBD ,_, but_CC the_DT depletion_NN of_IN
          gamma-tocopherol_JJ was_VBD always_RB faster_RBR than_IN that_DT of_IN
          alpha-tocopherol_JJ ._.
          The_DT changes_NNS in_IN tocopherol_NN levels_NNS (_( expressed_VBD as_IN
          nmoles_NNS /_NN well_RB )_) in_IN the_DT medium_NN were_VBD also_RB measured_VBN during_IN both_DT
          the_DT uptake_NN and_CC depletion_NN phases_NNS and_CC these_DT data_NNS are_VBP
          provided_VBN in_IN Tables_NNP 1_CD (_( for_IN alpha-tocopherol_JJ or_CC
          gamma-tocopherol_JJ )_) and_CC 2_CD (_( for_IN alpha-tocopherol_JJ plus_CC
          gamma-tocopherol_JJ )_) ._. In_IN order_NN to_TO make_VB meaningful_JJ
          comparison_NN ,_, Tables_NNP 1_CD and_CC 2_CD also_RB provide_VB the_DT cell_NN content_NN of_IN
          tocopherols_NNS expressed_VBD as_IN nmoles_NNS /_NN well_RB ._. The_DT data_NNS in_IN Tables_NNP
          1_CD and_CC 2_CD indicate_VBP that_IN only_RB a_DT small_JJ percentage_NN of_IN the_DT
          tocopherols_NNS lost_VBD from_IN the_DT medium_NN during_IN the_DT uptake_NN phase_NN
          are_VBP recovered_VBN in_IN the_DT macrophages_NNS ._. This_DT suggests_VBZ that_IN a_DT
          considerable_JJ amount_NN of_IN tocopherol_NN is_VBZ lost_VBN during_IN
          incubation_NN by_IN catabolism_NN /_NN oxidation_NN ._. The_DT recovery_NN of_IN
          alpha-tocopherol_JJ during_IN the_DT uptake_NN phase_NN was_VBD ,_, however_RB ,_,
          greater_JJR when_WRB gamma-tocopherol_JJ was_VBD present_JJ ._.
          It_PRP is_VBZ interesting_JJ that_IN the_DT depletion_NN of_IN
          alpha-tocopherol_JJ from_IN the_DT medium_NN during_IN the_DT uptake_NN phase_NN
          was_VBD always_RB greater_JJR than_IN that_DT of_IN gamma-tocopherol_JJ yet_RB the_DT
          cellular_JJ uptake_NN of_IN gamma-tocopherol_JJ was_VBD always_RB greater_JJR
          than_IN that_DT of_IN alpha-tocopherol_JJ ._. Tables_NNP 1_CD and_CC 2_CD also_RB indicate_VBP
          that_IN gamma-tocopherol_JJ decreases_NNS from_IN RAW_NNP 264_CD ._. 7_CD macrophages_NNS
          more_RBR rapidly_RB than_IN alpha-tocopherol_JJ during_IN the_DT depletion_NN
          phase_NN ._.
          Tocopheryl_NNP quinones_NNS (_( see_VB Figure_NN 2_LS )_) are_VBP likely_JJ products_NNS
          formed_VBN by_IN the_DT oxidation_NN of_IN tocopherols_NNS ._. Table_NNP 3_CD shows_VBZ the_DT
          initial_JJ distribution_NN of_IN alpha-tocopherol_JJ or_CC
          gamma-tocopherol_JJ and_CC their_PRP$ quinone_NN products_NNS both_DT in_IN the_DT
          medium_NN and_CC in_IN cells_NNS as_RB well_RB as_IN the_DT distribution_NN after_IN 6_CD
          hr_NN of_IN incubation_NN in_IN the_DT cell_NN system_NN ._. These_DT data_NNS show_VBP that_IN
          the_DT nmoles_NNS of_IN tocopherol_NN that_WDT accumulated_VBN in_IN cells_NNS after_IN
          6_CD hr_NN is_VBZ very_RB small_JJ compared_VBN to_TO the_DT amount_NN in_IN the_DT medium_NN ._.
          For_IN the_DT data_NNS in_IN Table_NNP 3_CD ,_, for_IN example_NN ,_, the_DT original_JJ amount_NN
          of_IN alpha-tocopherol_JJ in_IN the_DT medium_NN was_VBD 17_CD ._. 0_CD nmole_NN /_NN well_RB ,_,
          but_CC the_DT amount_NN present_JJ in_IN cells_NNS after_IN 6_CD hr_NN was_VBD just_RB 0_CD ._. 16_CD
          nmole_NN /_NN well_RB ,_, i_NNP ._. e_SYM ._. ,_, less_JJR than_IN 1_CD ._. 0_CD %_NN of_IN the_DT original_JJ amount_NN
          in_IN the_DT medium_NN ._. The_DT original_JJ amount_NN of_IN gamma-tocopherol_JJ
          was_VBD 14_CD ._. 8_CD nmole_NN /_NN well_RB ,_, and_CC the_DT amount_NN present_JJ in_IN cells_NNS
          after_IN 6_CD hr_NN was_VBD 0_CD ._. 86_CD nmole_NN /_NN well_RB ,_, which_WDT is_VBZ 5_CD ._. 8_CD %_NN of_IN the_DT
          original_JJ amount_NN in_IN the_DT medium_NN ._.
          If_IN tocopheryl_NN quinones_NNS were_VBD the_DT only_RB
          catabolic_JJ /_NN oxidation_NN products_NNS formed_VBN during_IN incubation_NN
          with_IN the_DT macrophages_NNS ,_, then_RB the_DT nmoles_NNS of_IN tocopherol_NN plus_CC
          the_DT nmoles_NNS of_IN tocopheryl_NN quinone_NN in_IN the_DT medium_NN and_CC in_IN the_DT
          cells_NNS should_MD be_VB constant_JJ ._. Table_NNP 3_CD clearly_RB shows_VBZ that_IN the_DT
          sum_NN of_IN the_DT tocopherol_NN and_CC its_PRP$ quinone_NN product_NN decreased_VBD
          over_IN the_DT 6_CD hr_NN experiment_NN suggesting_VBG that_IN products_NNS ,_, other_JJ
          than_IN the_DT tocopheryl_NN quinone_NN ,_, were_VBD formed_VBN during_IN the_DT
          experiment_NN ._. Moreover_RB ,_, these_DT data_NNS show_VBP that_IN after_IN 6_CD hr_NN of_IN
          incubation_NN :_: (_( 1_LS )_) cellular_JJ alpha-tocopheryl_JJ quinone_NN levels_NNS
          were_VBD generally_RB higher_JJR than_IN those_DT of_IN gamma-tocopheryl_JJ
          quinone_NN ;_: (_( 2_LS )_) cellular_JJ tocopheryl_NN quinones_NNS levels_NNS were_VBD
          always_RB much_RB lower_JJR than_IN cellular_JJ tocopherol_NN levels_NNS ._. This_DT
          latter_JJ point_NN suggests_VBZ that_IN the_DT low_JJ cellular_JJ levels_NNS of_IN
          alpha-tocopherol_JJ (_( compared_VBN to_TO gamma-tocopherol_JJ levels_NNS )_)
          shown_VBN in_IN Figure_NN 3_CD A_DT ,_, as_IN compared_VBN to_TO Figure_NN 3_CD B_NNP ,_, cannot_NN be_VB
          explained_VBN by_IN the_DT simple_JJ cellular_JJ oxidation_NN of_IN
          alpha-tocopherol_JJ to_TO alpha-tocopheryl_JJ quinone_NN (_( with_IN no_DT
          further_JJ catabolism_NN or_CC oxidation_NN )_) ._. After_IN 6_CD hr_NN ,_, macrophages_NNS
          incubated_JJ with_IN both_DT alpha-_NN and_CC gamma-tocopherol_JJ
          accumulated_VBN about_IN 0_CD ._. 5_CD nmole_NN more_RBR alpha-tocopherol_JJ than_IN
          did_VBD macrophages_NNS incubated_JJ with_IN alpha-tocopherol_JJ alone_RB ._.
          If_IN ,_, in_IN the_DT absence_NN of_IN gamma-tocopherol_JJ ,_, 0_CD ._. 5_CD nmole_NN of_IN
          alpha-tocopherol_JJ were_VBD converted_VBN to_TO alpha-tocopheryl_JJ
          quinone_NN (_( and_CC no_DT further_JJ catabolism_NN occurred_VBD )_) than_IN this_DT
          should_MD be_VB recovered_VBN in_IN cells_NNS ._. The_DT data_NNS in_IN Table_NNP
          3_CD indicate_VBP ,_, however_RB ,_, a_DT cellular_JJ accumulation_NN of_IN only_RB about_IN
          0_CD ._. 03_CD nmoles_NNS of_IN alpha-tocopheryl_JJ quinone_NN ._. Moreover_RB ,_,
          macrophages_NNS actually_RB had_VBD a_DT lower_JJR content_NN of_IN
          alpha-tocopheryl_JJ quinone_NN when_WRB incubated_JJ with_IN
          alpha-tocopherol_JJ alone_RB then_RB when_WRB incubated_JJ with_IN both_DT
          alpha-_NN and_CC gamma-tocopherol_JJ together_RB ._. Although_IN
          gamma-tocopherol_JJ promotes_VBZ the_DT cellular_JJ uptake_NN of_IN
          alpha-tocopherol_JJ ,_, it_PRP clearly_RB did_VBD not_RB do_VB so_RB by_IN
          dramatically_RB protecting_VBG alpha-tocopherol_JJ from_IN oxidation_NN
          to_TO alpha-tocopheryl_JJ quinone_NN (_( with_IN no_DT further_JJ
          catabolism_NN /_NN oxidation_NN of_IN alpha-tocopheryl_JJ quinone_NN )_) ._.
        
        
          The_DT uptake_NN and_CC depletion_NN tocopheryl_NN quinones_NNS
          (_( separately_RB and_CC together_RB )_)
          RAW_NNP 264_CD ._. 7_CD macrophages_NNS were_VBD incubated_JJ with_IN 0_CD ._. 6_CD μM_NN
          alpha-tocopheryl_JJ quinone_NN or_CC 0_CD ._. 4_CD μM_NN gamma-tocopheryl_JJ
          quinone_NN alone_RB (_( Figure_NN 4_CD A_DT )_) or_CC with_IN both_DT together_RB (_( Figure_NN
          4_CD Bwith_NNP 0_CD ._. 6_CD μM_NN alpha-tocopheryl_JJ quinone_NN and_CC 0_CD ._. 4_CD μM_NN
          gamma-tocopheryl_JJ quinone_NN )_) and_CC the_DT uptake_NN and_CC depletion_NN
          measured_VBN as_IN described_VBN above_IN ._. Figure_NN 4_CD indicates_VBZ that_IN
          alpha-tocopheryl_JJ quinone_NN accumulates_NNS to_TO higher_JJR levels_NNS
          than_IN gamma-tocopheryl_JJ quinone_NN (_( e_SYM ._. g_SYM ._. at_IN 6_CD hours_NNS the_DT
          difference_NN is_VBZ significant_JJ at_IN p_NN <_NN 0_CD ._. 001_CD )_) ._. Similarly_RB ,_,
          alpha-tocopheryl_JJ quinone_NN was_VBD lost_VBN from_IN the_DT cells_NNS more_RBR
          rapidly_RB during_IN the_DT depletion_NN phase_NN ._. These_DT results_NNS are_VBP
          consistent_JJ with_IN those_DT in_IN Table_NNP 3_CD ,_, which_WDT always_RB indicate_VBP a_DT
          higher_JJR intracellular_NN concentration_NN of_IN alpha-tocopheryl_JJ
          quinone_NN compared_VBN to_TO gamma-tocopheryl_JJ quinone_NN ._.
          Table_NNP 4_CD shows_VBZ the_DT initial_JJ distribution_NN of_IN
          alpha-tocopheryl_JJ quinone_NN or_CC gamma-tocopheryl_JJ quinone_NN in_IN
          both_DT the_DT medium_NN and_CC cells_NNS and_CC the_DT distribution_NN after_IN 6_CD hr_NN
          of_IN incubation_NN with_IN each_DT quinone_NN separately_RB or_CC both_DT
          quinones_NNS together_RB ._. Only_RB a_DT very_RB small_JJ fraction_NN of_IN the_DT
          gamma-tocopheryl_JJ quinone_NN lost_VBD from_IN the_DT medium_NN was_VBD taken_VBN
          up_RP by_IN the_DT RAW_NNP 264_CD ._. 7_CD macrophages_NNS ,_, i_NNP ._. e_SYM ._. 2_CD %_NN when_WRB
          gamma-tocopheryl_JJ quinone_NN was_VBD incubated_JJ by_IN alone_RB and_CC 2_CD %_NN
          when_WRB gamma-tocopheryl_JJ was_VBD incubated_JJ along_IN with_IN
          alpha-tocopheryl_JJ quinone_NN ._. In_IN the_DT case_NN of_IN alpha-tocopheryl_JJ
          quinone_NN there_EX was_VBD substantially_RB greater_JJR recovery_NN ,_, i_NNP ._. e_SYM ._. 23_CD
          %_NN when_WRB alpha-tocopheryl_JJ alone_RB was_VBD incubated_JJ with_IN the_DT
          macrophages_NNS and_CC 35_CD %_NN when_WRB alpha-tocopheryl_JJ quinone_NN was_VBD
          incubated_JJ along_IN with_IN gamma-tocopheryl_JJ quinone_NN ._. The_DT data_NNS
          in_IN Table_NNP 4_CD clearly_RB show_NN that_IN gamma-tocopheryl_JJ quinone_NN was_VBD
          oxidized_JJ and_CC /_NN or_CC catabolized_JJ more_RBR rapidly_RB than_IN
          alpha-tocopheryl_JJ quinone_NN ._. The_DT data_NNS in_IN Table_NNP 4_CD also_RB
          indicate_VBP that_IN cellular_JJ quinone_NN uptake_NN of_IN was_VBD not_RB
          influence_VB by_IN an_DT interaction_NN between_IN alpha-_NN and_CC
          gamma-tocopheryl_JJ quinones_NNS ._.
        
      
      
        Discussion_NNP
        
          The_DT uptake_NN and_CC depletion_NN of_IN tocopherols_NNS (_( separately_RB
          and_CC together_RB )_)
          Our_PRP$ results_NNS consistently_RB show_VBP that_IN gamma-tocopherol_JJ
          was_VBD taken_VBN up_RP more_RBR rapidly_RB and_CC accumulated_VBN to_TO higher_JJR
          intracellular_NN levels_NNS than_IN alpha-tocopherol_JJ ._. Moreover_RB ,_, the_DT
          presence_NN of_IN gamma-tocopherol_JJ markedly_RB promoted_VBD the_DT uptake_NN
          of_IN alpha-tocopherol_JJ by_IN macrophages_NNS ._. When_WRB macrophages_NNS were_VBD
          incubated_JJ with_IN alpha-tocopherol_JJ or_CC gamma-tocopherol_JJ
          individually_RB ,_, the_DT macrophage_NN level_NN of_IN alpha-tocopherol_JJ
          was_VBD just_RB 10_CD -_: 20_CD %_NN of_IN that_DT of_IN gamma-tocopherol_JJ (_( Figure_NN 3_CD A_DT )_) ._.
          In_IN marked_JJ contrast_NN ,_, when_WRB macrophages_NNS were_VBD incubated_JJ with_IN
          both_DT alpha-_NN and_CC gamma-tocopherols_JJ together_RB the_DT cellular_JJ
          level_NN of_IN alpha-tocopherol_JJ were_VBD 70_CD -_: 80_CD %_NN (_( after_IN 6_CD hr_NN )_) that_IN
          of_IN gamma-tocopherol_JJ (_( Figure_NN 3_CD B_NNP )_) ._. There_EX were_VBD no_DT marked_VBD
          changes_NNS in_IN the_DT levels_NNS of_IN gamma-tocopherol_JJ caused_VBN by_IN the_DT
          presence_NN of_IN alpha-tocopherol_JJ ._.
          Tocopherol_NNP quinones_NNS were_VBD considered_VBN to_TO be_VB likely_JJ
          oxidization_NN products_NNS of_IN the_DT tocopherols_NNS ._. The_DT increased_VBN
          cellular_JJ uptake_NN of_IN alpha-tocopherol_JJ caused_VBN by_IN
          gamma-tocopherol_JJ could_MD be_VB caused_VBN by_IN gamma-tocopherol_JJ
          protecting_VBG alpha-tocopherol_JJ from_IN 
          in_IN vitro_NN oxidation_NN to_TO its_PRP$ quinone_NN
          form_NN ._. However_RB ,_, the_DT data_NNS in_IN Table_NNP 3_CD show_NN that_IN
          gamma-tocopherol_JJ does_VBZ not_RB slow_VB the_DT oxidation_NN of_IN
          alpha-tocopherol_JJ to_TO alpha-tocopheryl_JJ quinone_NN ._. In_IN the_DT
          presence_NN of_IN gamma-tocopherol_JJ ,_, the_DT cellular_JJ levels_NNS of_IN
          alpha-tocopheryl_JJ quinone_NN were_VBD even_RB higher_JJR than_IN in_IN its_PRP$
          absence_NN (_( Table_NNP 3_LS )_) ._. It_PRP is_VBZ possible_JJ ,_, however_RB ,_, that_IN
          gamma-tocopherol_JJ may_MD protect_VB alpha-tocopherol_JJ from_IN
          catabolism_NN (_( or_CC 
          in_IN vitro_NN oxidation_NN )_) into_IN products_NNS
          other_JJ than_IN quinones_NNS ._. The_DT data_NNS in_IN Table_NNP 3_CD certainly_RB suggest_VBP
          that_IN products_NNS ,_, other_JJ than_IN quinones_NNS ,_, were_VBD produced_VBN when_WRB
          the_DT macrophages_NNS were_VBD incubated_JJ with_IN tocopherols_NNS ._. Those_DT
          metabolites_NNS could_MD very_RB possibly_RB be_VB water-soluble_JJ
          products_NNS ,_, such_JJ as_IN alpha-_NN CEHC_NNP or_CC gamma-_NN CEHC_NNP that_WDT were_VBD not_RB
          measured_VBN in_IN this_DT investigation_NN ._.
          It_PRP is_VBZ not_RB clear_JJ why_WRB our_PRP$ result_NN differ_VB from_IN those_DT
          reported_VBN by_IN Jiang_NNP 
          et_CC al_NN ._. [_NN 14_CD ]_NN who_WP also_RB measured_VBD
          the_DT uptake_NN of_IN alpha-_NN and_CC gamma-tocopherol_JJ separately_RB in_IN
          RAW_NNP 264_CD ._. 7_CD macrophages_NNS (_( but_CC not_RB both_DT together_RB )_) ._. Since_IN
          gamma-tocopherol_JJ is_VBZ depleted_VBN from_IN macrophages_NNS more_RBR
          rapidly_RB than_IN alpha-tocopherol_JJ the_DT time_NN interval_NN between_IN
          removal_NN of_IN the_DT tocopherol_NN enriched_JJ medium_NN and_CC cell_NN
          harvesting_NN could_MD be_VB an_DT important_JJ variable_NN ._. Our_PRP$ results_NNS
          are_VBP ,_, however_RB ,_, qualitatively_RB very_RB similar_JJ to_TO those_DT
          reported_VBN by_IN Tran_NNP and_CC Chen_NNP [_NN 13_CD ]_NN for_IN human_JJ endothelial_NN
          cells_NNS although_IN these_DT investigators_NNS did_VBD not_RB directly_RB
          compare_VB the_DT results_NNS from_IN incubating_VBG cells_NNS with_IN
          alpha-tocopherol_JJ and_CC gamma-tocopherol_JJ separately_RB or_CC
          together_RB ._.
        
        
          The_DT uptake_NN and_CC depletion_NN tocopheryl_NN quinones_NNS
          (_( separately_RB and_CC together_RB )_)
          When_WRB macrophages_NNS were_VBD incubated_JJ tocopheryl_NN quinones_NNS
          (_( see_VB Figure_NN 4_LS )_) ,_, the_DT cellular_JJ levels_NNS of_IN alpha-tocopheryl_JJ
          quinone_NN were_VBD always_RB found_VBN to_TO be_VB higher_JJR than_IN that_DT of_IN
          gamma-tocopheryl_JJ quinone_NN (_( independent_JJ of_IN the_DT presence_NN of_IN
          gamma-tocopheryl_JJ quinone_NN )_) ._. The_DT data_NNS in_IN Table_NNP 4_CD suggest_VBP
          that_IN alpha-tocopheryl_JJ quinone_NN is_VBZ fairly_RB stable_JJ in_IN the_DT
          cell_NN incubation_NN system_NN compared_VBN to_TO gamma-tocopheryl_JJ
          quinone_NN ._.
        
        
          Physiological_NNP significance_NN of_IN the_DT results_NNS
          It_PRP is_VBZ not_RB known_VBN if_IN the_DT 
          in_IN vitro_NN results_NNS of_IN this_DT study_NN are_VBP
          relevant_JJ to_TO the_DT 
          in_IN vivo_NN conditions_NNS ._. It_PRP is_VBZ
          interesting_JJ ,_, however_RB ,_, that_IN in_IN an_DT animal_NN model_NN ,_, graded_JJ
          levels_NNS of_IN dietary_JJ gamma-tocopherol_JJ in_IN a_DT diet_NN containing_VBG a_DT
          constant_JJ level_NN of_IN alpha-tocopherol_JJ were_VBD found_VBN to_TO increase_VB
          the_DT levels_NNS of_IN alpha-tocopherol_JJ in_IN serum_NN and_CC most_JJS tissues_NNS
          [_NN 16_CD ]_NN ._. This_DT remarkable_JJ result_NN has_VBZ yet_RB to_TO be_VB reproduced_VBD
          in_IN humans_NNS but_CC certainly_RB suggests_VBZ an_DT interaction_NN between_IN
          dietary_JJ gamma-tocopherol_JJ and_CC alpha-tocopherol_JJ similar_JJ to_TO
          that_DT reported_VBD here_RB on_IN the_DT cellular_JJ level_NN ._. The_DT potential_JJ
          health_NN related_VBD significance_NN of_IN gamma-tocopherol_JJ is_VBZ being_VBG
          increasingly_RB recognized_VBN [_NN 17_CD ]_NN ._.
        
      
      
        Conclusions_NNP
        Our_PRP$ data_NNS suggests_VBZ that_IN gamma-tocopherol_JJ could_MD play_VB a_DT
        significant_JJ role_NN in_IN modulating_VBG intracellular_NN antioxidant_NN
        defence_NN mechanisms_NNS ._. Moreover_RB ,_, we_PRP found_VBD the_DT presence_NN of_IN
        gamma-tocopherol_JJ dramatically_RB influenced_VBD the_DT cellular_JJ
        accumulation_NN of_IN alpha-tocopherol_JJ ,_, i_NNP ._. e_SYM ._. ,_, gamma-tocopherol_JJ
        promoted_VBD the_DT accumulation_NN of_IN alpha-tocopherol_JJ ._. If_IN these_DT
        results_NNS could_MD be_VB extrapolated_VBN to_TO 
        in_IN vivo_NN conditions_NNS they_PRP suggest_VBP that_IN
        gamma-tocopherol_JJ is_VBZ selectively_RB taken_VBN up_RP by_IN cells_NNS and_CC
        removed_VBN from_IN plasma_NN more_RBR rapidly_RB than_IN alpha-tocopherol_JJ ._.
        This_DT could_MD ,_, in_IN part_NN ,_, contribute_VB to_TO the_DT selective_JJ
        maintenance_NN of_IN alpha-tocopherol_JJ in_IN plasma_NN compared_VBN to_TO
        gamma-tocopherol_JJ ._.
      
      
        List_NN of_IN abbreviations_NNS
        α-_NN TOH_NNP ,_, RRR-alpha-tocopherol_NNP ;_: γ-_NN TOH_NNP ,_,
        RRR-gamma-tocopherol_NNP ;_: α-_NN TQ_NNP ,_, RRR-alpha-tocopheryl_NNP quinone_NN ;_:
        γ-_NN TQ_NNP ,_, RRR-gamma-tocopheryl_NNP quinone_NN ;_: gamma-_NN CEHC_NNP ,_, 2_CD ,_, 7_CD ,_,
        8_CD -_: trimethyl-_NN 2_CD -_: (_( beta-carboxyethyl_JJ )_) -_: 6_CD -_: hydroxychroman_NN ._.
      
    
  
